Drug Profile
Lexipafant
Alternative Names: BB 882; DO 6; GR 167089; Lexipafant - Vernalis; ZacutexLatest Information Update: 09 Apr 2021
Price :
$50
*
At a glance
- Originator Vernalis
- Developer DevCo Pharmaceuticals
- Class Anti-inflammatories; Antiasthmatics; Antiplatelets; Branched-chain amino acids; Imidazoles; Neuroprotectants; Small molecules
- Mechanism of Action Platelet activating factor inhibitors; Platelet activating factor stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cognition disorders; Neurological disorders; Pancreatitis; Reperfusion injury
- Discontinued Arrhythmias; Asthma; Ischaemic heart disorders; Multiple sclerosis